Long-COVID Rate May Be Higher With Rheumatic Diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients with rheumatic disease.
Medscape Medical News
source https://www.medscape.com/viewarticle/991466?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/991466?src=rss
Comments
Post a Comment